Atara Biotherapeutics, Inc. (LON:0HIY)

Atara Biotherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	94	61	41	258	1,029	1,191
Market Cap Growth	105.59%	49.24%	-84.11%	-74.90%	-13.57%	76.82%
Enterprise Value	96	47	9	102	783	961
Last Close Price	12.88	10.42	11.43	66.91	309.26	476.45
PS Ratio	0.83	0.60	6.10	4.89	68.51	-
PB Ratio	-3.44	-0.79	-0.53	2.46	4.98	3.52
P/TBV Ratio	-	-	-	2.46	4.98	3.52
EV/Sales Ratio	0.85	0.46	1.36	1.93	52.15	-
Debt / Equity Ratio	-0.46	-0.47	-0.58	0.57	0.10	0.03
Asset Turnover	1.76	0.94	0.03	0.15	0.04	-
Inventory Turnover	-	16.58	40.39	-	-	-
Quick Ratio	0.87	0.33	0.60	3.60	3.53	6.06
Current Ratio	1.02	0.48	0.72	3.74	3.64	6.31
Return on Equity (ROE)	-	-	-2014.86%	-112.39%	-91.69%	-81.43%
Return on Assets (ROA)	30.86%	-35.66%	-62.11%	-40.63%	-40.29%	-41.49%
Return on Capital (ROIC)	-	-	-214.41%	-67.79%	-54.20%	-49.28%
Return on Capital Employed (ROCE)	352.50%	307.50%	-1156.80%	-92.30%	-94.00%	-61.20%
Earnings Yield	18.60%	-111.40%	-528.31%	-73.36%	-24.41%	-18.86%
FCF Yield	-55.47%	-89.96%	-371.56%	-88.25%	-16.59%	-11.40%
Buyback Yield / Dilution	-102.28%	-76.77%	-3.83%	-8.88%	-26.63%	-44.17%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.